SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-316963
Filing Date
2021-11-02
Accepted
2021-11-02 16:16:32
Documents
59
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 6-K d207254d6k.htm   iXBRL 6-K 146972
2 EX-99.1 d207254dex991.htm   iXBRL EX-99.1 726635
3 EX-99.2 d207254dex992.htm EX-99.2 114933
  Complete submission text file 0001193125-21-316963.txt   4788250

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mreo-20210930.xsd EX-101.SCH 56151
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mreo-20210930_cal.xml EX-101.CAL 40499
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mreo-20210930_def.xml EX-101.DEF 186890
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE mreo-20210930_lab.xml EX-101.LAB 330710
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mreo-20210930_pre.xml EX-101.PRE 272921
9 EXTRACTED XBRL INSTANCE DOCUMENT d207254d6k_htm.xml XML 890862
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo Biopharma Group plc (Filer) CIK: 0001719714 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38452 | Film No.: 211371517
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences